June 19, 2015
11 am to 12 pm EDT

Sponsored by
Agena Bioscience

Webinar Description:

Dr. Robin Everts of Agena Bioscience™, and Dr. Tara Paton from The Centre for Applied Genomics at The Hospital for Sick Children in Toronto, will discuss the important role of PGx in modern precision medicine, factors influencing wider adoption, and highlight the key benefits of pharmacogenetic genotyping using the MassARRAY® System. The benefits include detection of different genetic modifications (CNV, indel, SNP) in a single assay and the flexibility to perform comprehensive analyses of multiple ADME-related genes, or a focused analysis of a single gene such as CYP2D6 with ease.

Learning Objective:

  • Pharmacogenetics as an important component of precision medicine
  • Factors likely to influence faster and wider adoption of PGx
  • Benefits of the MassARRAY System for routine PGx sample analysis
  • PGx data analysis and reporting software

Who Should Attend:

  • Directors/CEOs of Toxicology Labs interested in expanding their business
  • Lab Managers running PGx tests who wish to expand their PGx assay capabilities
  • Pharmacogenetics researchers who want a powerful and flexible genetic analysis system for their research
  • Directors/Managers of clinical research trials who wish to stratify trial participants
  • Pharmacists interested in understanding how PGx can support drug choice and dosage


Robin EvertsRobin Everts, Ph.D.

Manager, Applications and Technology Support

Agena Bioscience, Inc.

Dr. Robin Everts, Manager of Applications & Technology Support at Agena Bioscience, oversees the Assays by Agena custom assay development laboratory and new customer training on the MassARRAY System. Over the last eight years, Dr. Everts has developed genotyping, somatic mutation analysis, and DNA methylation assays for over 100 applications including pharmacogenetics. Dr. Everts is a contributor to the CDC’s Genetic Testing Reference Materials Coordination Program (GeT-RM, Pharmacogenomics workgroup), for which he created and tested the ADME PGx Pro Panel. Dr. Everts was trained as a molecular geneticist and has published over 40 peer-reviewed articles in different fields including gene expression in immunology, developmental biology, and gene mapping.

Tara PatonTara Paton, Ph.D.

Manager, Genetic Analysis Facility

The Centre for Applied Genomics
The Hospital for Sick Children

Dr. Tara Paton is manager of the Genetic Analysis Facility at The Centre for Applied Genomics (TCAG), embedded in The Hospital for Sick Children in Toronto, Canada. Dr. Paton has been in her role for over 10 years, overseeing a variety of genotyping platforms in her laboratory that are applied to research studies in genetics and genome biology. Dr. Paton is also a key contributor to the team at Sick Kids that is working to implement routine clinical pharmacogenetic testing on the MassARRAY platform. Dr. Paton is a trained molecular geneticist and has published in the fields of phylogenetics, human disease gene identification, and copy number variation.

Cost: No cost